ArticleStem cell reviews and reports2026
Exosome Purification Strategy Influences the Regenerative Efficacy of Dental Pulp Stem Cell-Derived Exosomes in Bone Regeneration.
Article in Stem cell reviews and reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Dental pulp cell-derived conditioned culture media promotes periodontal repair through immunomodulation and bone regeneration.Regenerative therapy · 2026Article
- Exosome-mediated muscle-bone crosstalk: mechanisms and therapeutic potential.Journal of translational medicine · 2026Review
- Exosomes in osteoporosis: regulatory mechanisms and clinical applications.Frontiers in physiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundMesenchymal stem cell (MSC)-based tissue engineering is largely mediated by extracellular vesicles (EVs), particularly exosomes (Exos). The biological activity of Exos is strongly influenced by the isolation method, yet no standardized approach exists.
methodsDental pulp stem cell (DPSC)-derived Exos were isolated using ultracentrifugation (UC) or size exclusion chromatography (SEC). UC-Exos and SEC-Exos were characterized for morphology, size, yield, protein content, and proteomic profiles. Their effects on periodontal ligament stem cells (PDLSCs) were assessed, including proliferation, migration, and osteogenic differentiation. In vivo bone regeneration was evaluated in rat calvarial defects using Exos combined with bone-grafting material.
resultsSEC-Exos yielded exosomes with higher purity, greater particle counts, and lower protein contamination than UC-Exos. Proteomic profiling showed enrichment of osteogenic factors, including ENPP2 and afamin, in SEC-Exos. Functionally, UC-Exos promoted PDLSC proliferation and migration, while SEC-Exos more effectively enhanced osteogenic differentiation. Both Exos improved PDLSC functions dose-dependently and, when combined with bone grafts, consistently promoted calvarial bone regeneration. Notably, osteocalcin expression was higher in SEC-Exos-treated defects.
conclusionsThe isolation method critically determines the biological performance of DPSC-derived Exos. UC-Exos may be preferable for stimulating proliferation and migration, whereas SEC-Exos show advantages in osteogenic differentiation. Both approaches facilitated bone regeneration in vivo, suggesting that exosome isolation strategies should be tailored to experimental requirements and therapeutic objectives to optimize translational outcomes. SIGNIFICANCE STATEMENT: The isolation method critically determines the biological performance of DPSC-derived exosomes. SEC-Exos, enriched in osteogenic factors such as ENPP2 and afamin, preferentially enhanced osteogenic differentiation, whereas UC-Exos promoted proliferation and migration. Both approaches supported consistent bone regeneration in vivo, underscoring that the optimal isolation strategy should be tailored to specific experimental and therapeutic objectives to advance translational applications.
Indexed as
Identifiers
41082157What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.